Abstract
Introduction

TGF-␤ isoforms, activins and BMPs, constitute a large family with more than 33 members in human beings. Characteristically, members transmit signals via cell surface serine/threonine kinase receptors and intracellular Smad transcription factors
. Smads are segregated into three functional groups. Receptor Smads (R-Smads; Smads1, 2, 3, 5 and 8) [11] , thus assuring termination or reducing the strength of TGF-␤ signalling.
TGF-␤ is a master mediator in liver fibrogenesis [12] , TGF-␤ favours transition of HSCs to myofibroblasts, stimulates synthesis of ECM proteins, and inhibits their degradation. Strategies aimed at disrupting TGF-␤ synthesis and/or signalling pathways markedly decrease fibrosis in experimental models [13] . In line with this, we recently used an adenovirus-based gene therapeutic approach for ectopic Smad7 expression in liver cells and thus abrogated fibrogenesis in bile duct ligated rats [4] . [14, 15] . [16] . These results imply that low Smad7 levels are involved in progression of liver fibrosis.
The physiological role of Smad7 during liver damage is not clear. We found that quiescent HSCs in culture display a functional negative feedback comprising TGF-␤-dependent transient activation of Smad7 expression, which is lost in myofibroblasts
Studies analysing PAI-1 and Col1A2 expression in HSCs further support a model in which endogenous TGF-␤-mediated Smad7 terminates fibrotic signals, thus providing a transient TGF-␤ response after acute liver damage. In contrast, constitutive Smad2 activation and lack of Smad7 expression were present in MFBs throughout chronic liver injury
Recently, we generated a novel mouse model, denoted S7⌬E1, with a deletion of exon1 from the endogenous Smad7 gene, by replacing the coding region of Smad7 including the starting ATG codon and a part of intron I with a neomycin selection cassette via homologous recombination. This resulted in a deletion of roughly the first half of the Smad7 protein, i.e. the Nterminal 204 aa. Mice heterozygous or homozygous for this deletion were viable and fertile. Mutant B cells showed an overactive TGF-␤ signalling measured as increase of phosphorylated Smad2-positive B cells leading to increased Ig class switch recombination to IgA, enhanced B cell apoptosis, highlighting a prominent role for Smad7 in regulating the immune system's response to TGF-␤ [1].
To get further insight into Smad7 function during liver fibrogenesis in vivo, we examined these S7⌬E1 mice in a carbon tetrachloride (CCl 4 
Generation of Smad7 mutant mice
Smad7 exon1 deleted mice were generated as previously described [1] . Briefly, the Smad7 locus was isolated from a 129Sv genomic library [2] . [3] .
Liver histology
Liver specimen were fixed in 10% formalin and embedded them in paraffin. Tissue sections (4 m) were stained with haematoxylin and eosin for routine examination, or with picro-Sirius red for visualization of hepatic collagen deposition as described [4] 
Isolation of primary hepatocytes and treatment
In vitro studies were performed with primary hepatocytes isolated from livers of male wild-type or S7⌬E1 CD-1 mice (30-40 g, 8-12 weeks of age) using collagenase perfusion as described previously [8] . Cells were plated on collagen-coated plates at a density of 4 ϫ 10 4 cells/cm 2 
in Williams' medium E (10% FBS, 2 mM L-glutamine, 1% penicillin/streptomycin and 100 nM dexamethasone). After 4 hrs attachment the medium was changed to Williams medium E (2 mM L-glutamine and 1% penicillin/streptomycin). Different substances for treatment were added to serum-free culture medium for the indicated times and concentrations. Control conditions included cells maintained for the same period in serum-free medium supplemented with the solvent chemical.
The in vitro experiments were done in duplicates, using hepatocytes from two independent preparations. Cell lysates were collected from one well (Western blot analysis) and from two wells of a six-well plate for DNA laddering.
DNA laddering
Genomic DNA fragmentation was analysed as described [9] . Briefly (Fig. 3a and b) . Finally, the number of ␣-SMA positive cells was also higher in S7⌬E1 mice ( Fig. 3c and d) . Western blot analysis of liver lysates from these mice accordingly display the strongest ␣-SMA signal (Fig. 2c) .
Measurement of lactate dehydrogenase release
Lactate dehydrogenase (LDH) activity was measured in culture supernatants and cell lysates (0.1% Triton-X-100 in medium) using the cytotoxicity detection kit (LDH; Roche) according to the manufacturers' instructions. The OD ( = 492 nm/ref = 600 nm) was measured with a rainbow thermo ELISA reader (SLT Labinstruments, Auhof, Germany). Results are given as percentage of total LDH released. All experiments were performed in triplicates from three independent preparations of hepatocytes.
Measurement of reactive oxygen species (ROS), glutathione (GSH) and lipid peroxidation
Damage-induced increased levels of active TGF-␤ in the liver are described to act on hepatocytes by inducing apoptosis [17] . Disrupting the Smad7 gene lead to a moderate, but significant increase of apoptotic cell number in the liver, as determined by IHC using an antibody to cleaved Caspase-3 ( Fig. 3e and f) Fig. 3g and h ).
Increased sensitivity to TGF-␤-induced apoptosis in S7⌬E1 hepatocytes
Given the higher ratio of apoptotic cells after CCl 4 (Fig. 4a) .
TGF-␤-dependent DNA fragmentation results confirmed the microscopic features and display higher apoptosis rates in S7⌬E1
compared to wild-type cells (Fig. 4b) . Western analyses were also in agreement with higher TGF-␤-induced apoptosis in S7⌬E1 mice, showing clear poly-ADP-ribose-polymerase (PARP) degradation and stronger Caspase-3 activation in the Smad7 mutant background (Fig. 4c) . Remarkably, untreated S7⌬E1 cells are to some extent spontaneously undergoing apoptosis, as indicated by detection of active Caspase-3 protein (Fig. 4c) .
To further proof and compare cellular damage by TGF-␤, we measured LDH secretion into the culture medium. After 24 hrs, no significant difference in LDH release between S7⌬E1 and wildtype hepatocytes was apparent (data not shown), whereas after 48 hrs damage in S7⌬E1 cells was evident (Fig. 4d) (Fig. 5a-f (Fig. 6a) . In line with this, cellular GSH showed a more rapid decrease in S7⌬E1 hepatocytes (Fig. 6b) (Fig. 6c  and Fig. 6e and f) .
as direct measures of oxidative stress, ROS production and GSH depletion were determined. TGF-␤ stimulation resulted in rapid and transient production of ROS in cells from both backgrounds that peaked between 4 and 8 hrs. However, in S7⌬E1 hepatocytes TGF-␤-induced increase in ROS was faster and more prolonged
d). Finally, lipid peroxidation increased upon TGF-␤ and CCl 4 treatment in a dose-dependent manner and was higher in S7⌬E1 compared to wild-type hepatocytes (
It has previously been reported that CCl 4 induces an increase in serum levels of TGF-␤ 1 [18] . This observation points to the possibility that CCl 4 (Fig. 7a- (Fig. 8a) (Fig. 8b) . (Fig. 8c and d) . Similarly, Western blot results with whole liver protein lysates of the same animals display a stronger P-Smad2 band in S7⌬E1 mice (Fig. 2c) Fig. 8e and f; The role of TGF-␤ signalling in HSCs has been extensively studied [23] and it was found that negative feedback regulation via Smad7 only occurs in quiescent cells, whereas such a regulatory loop is absent in activated HSCs [15] . [16] . On the other hand, Smad7 expression is physiologically induced and was continuously increasing with duration of cholestasis during liver damage in bile duct ligated rats, when investigating whole liver lysates at RNA and protein level [24] . These conflicting results indicate that beside the general picture about Smad7 expression and negative regulation of TGF-␤ signalling cell type specific differences need to be taken into account.
incites damage due to modified TGF-␤ signalling instead of direct effects from the chemical itself. To proof this assumption, we repeated the experiments with primary hepatocyte cultures in presence or absence of the ALK-5 inhibitor SB431542. Cells were stimulated for 16 hrs with TGF-␤ and CCl 4 . The ALK-5 inhibitor indeed antagonized ROS production, GSH decrease and lipid peroxidation to a similar extent in both groups
c). SB431542 addition obliviated the differences between S7⌬E1 and wild-type hepatocytes in the assays. We conclude that increased oxidative stress in S7⌬E1 hepatocytes compared to wild-type mice resulted in enhanced cellular damage as observed by
Fig. 4 Smad7 mutation results in enhanced sensitivity to TGF-␤-induced apoptosis in hepatocytes. (a) Phase contrast microscopy of cultured hepatocytes from wild-type and S7⌬E1 mice. Day 1 hepatocytes show typical honeycomb shape. Cultures on day 3 present morphological features of EMT and apoptosis, which are more prominent with S7⌬E1 genetic background (see inserts); (b) DNA fragmentation and (c) immunoblot of active caspase-3 and PARP (full length and cleaved) as markers of apoptosis. Both methods show increased apoptosis rates in S7⌬E1 compared to wild-type mice; (d) CD1 wild-type and S7⌬E1 hepatocytes were treated for 48 hrs with different concentrations of TGF-␤ as indicated. Cellular damage was
Increased sensitivity to TGF-␤-induced signal transduction in S7⌬E1 hepatocytes
Analysing Smad2 phosphorylation in wild-type and S7⌬E1 hepatocytes 48 hrs after stimulation with 5 ng/ml TGF-␤ by Western blot indicates that disruption of Smad7 exon 1 results in a higher level of phospho-Smad2
TGF-␤-induced luciferase activity in S7⌬E1 cells almost fourfold more than in wild-type cells, indicating a stronger sensitivity to TGF-␤ due to the lack of an effective negative feedback regulation by the disrupted Smad7 gene. Under basal conditions, low luciferase activity was observed that, although minute compared to the levels after TGF-␤ stimulation, was higher in S7⌬E1 than wild-type cells. To analyse TGF-␤ signalling in vivo, we determined Smad2 Cterminal serine phosphorylation with immunohistochemistry. Application of CCl 4 for 8 weeks strongly induced TGF-␤ signalling in liver cells of CD-1 wild-type mice. In line with the in vitro data, the number of phospho-Smad2 positive nuclei was further increased in S7⌬E1 mice
Fig. 5 Increased sensitivity to cell damage of S7⌬E1 hepatocytes is not related to direct chemical effects. CD1 wild-type and S7⌬E1 hepatocytes were treated with five different concentrations of CCl 4 (a), DMSO (b), digoxin (c), acetaminophen (d), tetracycline (e) and verapamil (f). After 24 h,
In line with this, during acute liver injury, profibrogenic TGF-␤ signalling in HSCs was terminated by Smad7, thus providing a transient response to TGF-␤, whereas Smad7 was not induced in MFBs in vivo throughout chronic liver injury, thus allowing constitutive R-Smad activation and subsequent progression of liver fibrosis
Fig. 6 Loss of Smad7 function leads to increased oxidative stress by TGF-␤ and CCl 4 . CD1 wild-type and S7⌬E1 hepatocytes were treated with TGF-
␤ (a-c) or CCl 4 (d-f). During the first 48 hrs after treatment, levels of ROS (a, d) and cellular glutathione (b, e) were measured. After 72 hrs lipid
peroxidation (c, f) was determined. **P < 0.01 and ***P < 0.001 when comparing wild-type and S7⌬E1 hepatocytes under the same conditions. oo P < 0.01 and ooo P < 0.001 when comparing the different treatments to the control condition in wild-type hepatocytes. P < 0.001 when comparing the different treatments to the negative control in S7⌬E1 hepatocytes. [26] . In a chronic liver disease mouse model, we found increased inflammation in Smad7-deficient animals after CCl 4 intoxication, suggesting that the mechanism occurring in chronic IBD is not relevant in chronic liver disease.
In the diverse fibroproliferative diseases, TGF-␤ is mainly profibrogenic, whereas its anti-inflammatory role seems to be of minor relevance. However, in chronic inflammatory bowel disease (IBD), although active TGF-␤ is present, an anti-inflammatory role in the mucosa of inflamed regions and isolated mucosal T cells is abrogated by pathophysiological Smad7 over-expression [25]. An antisense approach targeting Smad7 mRNA restored TGF-␤ signalling in inflammatory cells and released the inhibitory effects of proinflammatory cytokine synthesis, e.g. IFN-␥ or tumour necrosis factor-␣ (TNF-␣). This indicates that Smad7 blunts TGF-␤ signalling in chronic bowel disease and thus helps to maintain chronic production of pro-inflammatory cytokines in the presence of TGF-␤
Because the number of ␣-SMA-positive cells, collagen deposition/expression and hydroxyproline content are increased in S7⌬E1 compared to wild-type mice after CCl 4 treatment, we conclude that lack of a functional Smad7 gene leads to enhanced TGF-␤ activation of HSCs.
We have previously shown [27, 28] [29] . Similarly, Smad7 impaired TGF-␤-induced apoptosis in Hep3B cells [30] . [31] . Similarly, in prostate carcinoma cells, Smad7 is required for TGF-␤-induced apoptosis, acting as stabilizer of a MAPK complex that leads to activation of p38 [32] .
Conversely, nuclear translocation of the cell survival factor NF-?B is inhibited by Smad7 in podocytes, thereby sensitizing cells to the pro-apoptotic effect of TGF-␤, which occurs in part via p38
In hepatocytes and in the non-differentiated hepatoma cell line AML12, p38 plays also a crucial role in apoptosis. However, in this cell-type it was shown that p38 activation relies on GADD45␤ expression, which is directly induced by Smad3 [33] 
